The primary goal is to predict the clinical outcomes of mother and baby using blood glucose and other routinely collected clinical data in pregnancy to predict adverse outcomes at birth in women with GDM. The secondary goal is to develop models to predict optimal blood glucose testing schedules for pregnant women. Exploratory Objectives are (1) to understand patterns of dosage and / or medication choice and (2) to describe different phenotypes of gestational diabetes based on multiple data input.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Clinical outcome of mothers at birth
Timeframe: From enrollment to the delivery date, assesed upto 52 weeks.
Clinical outcome of mothers after birth
Timeframe: From the delivery date to the date that mother was discharged from the hospital, assessed up to 52 weeks, whichever come first.
Clinical outcome of neonates at birth
Timeframe: From enrollment to the delivery date to the date to giving birth, assesed upto 52 weeks.
Clinical outcome of neonates after birth
Timeframe: From the delivery date to the date that neonate was discharged from the hospital, assessed up to 52 weeks, whichever come first.